Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cognetivity Neurosciences Ltd (OP: CGNSF )

0.0100 +0.0065 (+185.71%)
Streaming Delayed Price Updated: 3:15 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cognetivity Neurosciences Ltd

AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners
As psychedelics and AI travel their own development paths, here are some initiatives looking at ways of enhancing the former with the latter’s help. 
Via Benzinga
UK-Based Psychedelics Ancillary Business Wraps Up $3M Funding Round
A tech company responsible for creating a clinical testing platform that uses AI and machine learning for the detection of earliest cognitive impairment signs, Cognetivity Neurosciences Ltd. 
Via Benzinga
Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market
Image provided by Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Ketamine One Teams Up With Cognetivity Neurosciences To Study PTSD, Depression
Ketamine One, a Canada-based health and wellness company focused on treatments for mental health, is teaming up with Cognetivity Neurosciences (OTCMKTS: CGNSF) for a collaborative... 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.